TY - JOUR
T1 - Enzymatic synthesis of chiral amino-alcohols by coupling transketolase and transaminase-catalyzed reactions in a cascading continuous-flow microreactor system
AU - Gruber, Pia
AU - Carvalho, Filipe
AU - Marques, Marco P.C.
AU - O'Sullivan, Brian
AU - Subrizi, Fabiana
AU - Dobrijevic, Dragana
AU - Ward, John
AU - Hailes, Helen C.
AU - Fernandes, Pedro
AU - Wohlgemuth, Roland
AU - Baganz, Frank
AU - Szita, Nicolas
N1 - Publisher Copyright:
© 2017 The Authors. Biotechnology and Bioengineering Published by Wiley Periodicals, Inc.
PY - 2018/3
Y1 - 2018/3
N2 - Rapid biocatalytic process development and intensification continues to be challenging with currently available methods. Chiral amino-alcohols are of particular interest as they represent key industrial synthons for the production of complex molecules and optically pure pharmaceuticals. (2S,3R)-2-amino-1,3,4-butanetriol (ABT), a building block for the synthesis of protease inhibitors and detoxifying agents, can be synthesized from simple, non-chiral starting materials, by coupling a transketolase- and a transaminase-catalyzed reaction. However, until today, full conversion has not been shown and, typically, long reaction times are reported, making process modifications and improvement challenging. In this contribution, we present a novel microreactor-based approach based on free enzymes, and we report for the first time full conversion of ABT in a coupled enzyme cascade for both batch and continuous-flow systems. Using the compartmentalization of the reactions afforded by the microreactor cascade, we overcame inhibitory effects, increased the activity per unit volume, and optimized individual reaction conditions. The transketolase-catalyzed reaction was completed in under 10 min with a volumetric activity of 3.25 U ml−1. Following optimization of the transaminase-catalyzed reaction, a volumetric activity of 10.8 U ml−1 was attained which led to full conversion of the coupled reaction in 2 hr. The presented approach illustrates how continuous-flow microreactors can be applied for the design and optimization of biocatalytic processes.
AB - Rapid biocatalytic process development and intensification continues to be challenging with currently available methods. Chiral amino-alcohols are of particular interest as they represent key industrial synthons for the production of complex molecules and optically pure pharmaceuticals. (2S,3R)-2-amino-1,3,4-butanetriol (ABT), a building block for the synthesis of protease inhibitors and detoxifying agents, can be synthesized from simple, non-chiral starting materials, by coupling a transketolase- and a transaminase-catalyzed reaction. However, until today, full conversion has not been shown and, typically, long reaction times are reported, making process modifications and improvement challenging. In this contribution, we present a novel microreactor-based approach based on free enzymes, and we report for the first time full conversion of ABT in a coupled enzyme cascade for both batch and continuous-flow systems. Using the compartmentalization of the reactions afforded by the microreactor cascade, we overcame inhibitory effects, increased the activity per unit volume, and optimized individual reaction conditions. The transketolase-catalyzed reaction was completed in under 10 min with a volumetric activity of 3.25 U ml−1. Following optimization of the transaminase-catalyzed reaction, a volumetric activity of 10.8 U ml−1 was attained which led to full conversion of the coupled reaction in 2 hr. The presented approach illustrates how continuous-flow microreactors can be applied for the design and optimization of biocatalytic processes.
KW - cascading reactor system
KW - continuous-flow microreactors
KW - multi-step bioconversion
KW - transaminase
KW - transketolase
UR - http://www.scopus.com/inward/record.url?scp=85033397153&partnerID=8YFLogxK
U2 - 10.1002/bit.26470
DO - 10.1002/bit.26470
M3 - Article
C2 - 28986983
AN - SCOPUS:85033397153
SN - 0006-3592
VL - 115
SP - 586
EP - 596
JO - Biotechnology and Bioengineering
JF - Biotechnology and Bioengineering
IS - 3
ER -